[HTML][HTML] Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled …

MC Peedikayil, FI AlSohaibani, AH Alkhenizan - PLoS One, 2014 - journals.plos.org
Background First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials

MC Peedikayil, FI AlSohaibani, AH Alkhenizan - PLoS ONE, 2014 - go.gale.com
Helicobacter pylori infection is one of the most common chronic human bacterial infections.
The consequences of infection are chronic gastritis, gastric and duodenal ulcers, gastric …

Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials.

MC Peedikayil, FI AlSohaibani, AH Alkhenizan - PLoS ONE, 2014 - search.ebscohost.com
Background: First-line levofloxacin-based treatments eradicate< i> Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.

MC Peedikayil, FI Alsohaibani, AH Alkhenizan - Plos one, 2014 - europepmc.org
Background First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials

MC Peedikayil, FI AlSohaibani, AH Alkhenizan - PLOS ONE, 2014 - econpapers.repec.org
Background: First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials

MC Peedikayil, FI Alsohaibani, AH Alkhenizan - PloS one, 2014 - pubmed.ncbi.nlm.nih.gov
Background First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials.

MC Peedikayil, FI Alsohaibani, AH Alkhenizan - 2014 - cabidigitallibrary.org
Background: First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

[PDF][PDF] Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials

MC Peedikayil, FI AlSohaibani, AH Alkhenizan - 2014 - pdfs.semanticscholar.org
Background: First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials

MC Peedikayil, FI AlSohaibani, AH Alkhenizan - PLOS ONE, 2014 - ideas.repec.org
Background: First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …

[PDF][PDF] Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials

MC Peedikayil, FI AlSohaibani, AH Alkhenizan - 2014 - Citeseer
Background: First-line levofloxacin-based treatments eradicate Helicobacter pylori with
varying success. We examined the efficacy and safety of first-line levofloxacin-based …